Table 4 Effect of CurNPs and ZnONPs administration on serum liver function enzymes (ALT, AST, and GGT levels) of STZ-induced diabetic and control rats.

From: Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes

Groups

ALT (U/L)

AST (U/L)

GGT (U/L)

Control

32.60 ± 0.93d

32.00 ± 0.71f.

11.00 ± 0.71d

HFD/STZ

212.60 ± 0.93a

243.61 ± 1.21a

52.20 ± 0.86a

HFD/STZ-Cur

61.40 ± 0.93b

53.60 ± 1.03d

20.80 ± 0.58b,c

HFD/STZ-CurNPs-10

31.80 ± 0.58d

42.40 ± 0.93e

20.60 ± 0.51b,c

HFD/STZ-CurNPs-50

32.40 ± 0.93d

40.00 ± 0.71e

19.80 ± 0.37c

HFD/STZ- ZnSO4

57.00 ± 1.41b

72.60 ± 0.93c

23.00 ± 1.00b

HFD/STZ-ZnONPs-10

32.00 ± 0.71d

36.00 ± 0.71f.

23.00 ± 0.71b

HFD/STZ-ZnONPs-50

36.40 ± 1.36c

37.00 ± 0.71f.

21.00 ± 0.71b

HFD/STZ-MT

31.00 ± 0.71d

87.80 ± 0.86b

19.60 ± 0.51c

  1. Values are expressed as mean ± SEM (n = 7), means for the same parameter with different letters in each column are significantly different (Tukey, p < 0.01).